首页> 美国卫生研究院文献>other >Metabolism of Secoisolariciresinol-Diglycoside The Dietary Precursor to The Intestinally Derived Lignan Enterolactone in Humans
【2h】

Metabolism of Secoisolariciresinol-Diglycoside The Dietary Precursor to The Intestinally Derived Lignan Enterolactone in Humans

机译:人体中肠道衍生的木质素肠内酯的饮食前体西异香豆素-二糖苷的代谢

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Secoisolariciresinol-diglycoside (SDG), a natural dietary lignan of flaxseeds now available in dietary supplements, is converted by intestinal bacteria to the mammalian lignans enterodiol and enterolactone. High levels of these lignans in blood and urine are associated with reduced risk of many chronic diseases. Our objective was to determine the bioavailability and pharmacokinetics of SDG in purified flaxseed extracts under dose-ranging and steady-state conditions, and to examine whether differences in secoisolariciresinol-diglycoside purity influence bioavailability. Pharmacokinetic studies were performed on healthy postmenopausal women after oral intake of 25, 50, 75, 86 and 172mg of secoisolariciresinol-diglycoside. Extracts differing in secoisolariciresinol-diglycoside purity were compared, and steady-state lignan concentrations measured after daily intake for one week. Blood and urine samples were collected at timed intervals and secoisolariciresinol, enterodiol and enterolactone concentrations measured by mass spectrometry. Secoisolariciresinol-diglycoside was efficiently hydrolyzed and converted to secoisolariciresinol. Serum concentrations increased rapidly after oral intake, peaking after 5-7h and disappearing with a plasma elimination half-life of 4.8h. Maximum serum concentrations of the biologically active metabolites, enterodiol and enterolactone were established after 12-24h and 24-36h, respectively, and the half-lives were 9.4h and 13.2h. Linear dose-responses were observed and secoisolariciresinol bioavailability correlated (r2=0.835) with cumulative lignan excretion. There were no significant differences in the pharmacokinetics of extracts differing in purity, and steady-state serum lignan concentrations were obtained after one-week of daily dosing. In conclusion, this study defines the pharmacokinetics of secoisolariciresinol-diglycoside and shows it is first hydrolyzed and then metabolized in a time-dependent sequence to secoisolariciresinol, enterodiol and ultimately enterolactone, and these metabolites are efficiently absorbed.
机译:二十二碳六烯四醇二糖苷(SDG)是一种亚麻籽的天然膳食木脂素,现在可以从膳食中获得,可通过肠细菌转化为哺乳动物的木脂素肠二醇和肠内酯。血液和尿液中这些木脂素的高水平与许多慢性疾病的风险降低有关。我们的目标是确定在剂量范围和稳态条件下纯化的亚麻籽提取物中SDG的生物利用度和药代动力学,并检查癸二异水芹树脂醇-二糖苷纯度的差异是否影响生物利用度。口服25、50、75、86和172毫克的异麦芽糖苷树脂-地二糖苷口服后,对健康的绝经后妇女进行了药代动力学研究。比较了癸二异西里香脂醇-二糖苷纯度不同的提取物,每天摄入一星期后测出稳态木脂素浓度。定时采集血液和尿液样品,并通过质谱法测定癸异异西里烯醇,肠二醇和肠内酯的浓度。芥子油苷树脂-二糖苷被有效地水解并转化为芥子油苷树脂。口服后血清浓度迅速增加,在5-7h后达到峰值,并以4.8h的血浆消除半衰期消失。生物活性代谢产物,肠二醇和肠内酯的最高血清浓度分别在12-24h和24-36h后确定,半衰期为9.4h和13.2h。观察到线性剂量反应,并且异豆香脂树脂的生物利用度与累积木酚素排泄量相关(r 2 = 0.835)。纯度不同的提取物的药代动力学无显着差异,每天给药一周后可获得稳态血清木脂素浓度。总而言之,这项研究定义了山核桃异麦芽糖醇-地二糖苷的药代动力学,并显示它首先被水解,然后以时间依赖性的顺序代谢为山核桃异麦芽糖醇,肠二醇和最终肠内酯,并且这些代谢物被有效吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号